Biotechnology company CytoDyn appointed Scott Kelly, MD, as CMO and head of business development on April 13.
Three things to know:
1. Dr. Kelly specializes in nonsurgical spine care and has served as director of the spine center at Atlanta-based Resurgens Orthopaedics since 2007.
2. Since 2017, he has operated as a director at CytoDyn and will continue his role as chairman of the board.
3. CytoDyn is enrolling patients in two COVID-19 clinical trials: one for people with mild-to-moderate symptoms and another for those in critical condition.